International
The Morning Science

What science found today

‹
 

Research

G3BP1-induced retrograde transport blockade triggers HSC activation and liver fibrosis via COPI alternative splicing

Nature · By Enyi Wu ·

The Brief

  • Liver fibrosis is driven by hepatic stellate cell activation, and its molecular drivers are not fully understood.
  • The study reports that G3BP1 promotes COPI alternative splicing via SRPK1–hnRNPM.
  • The authors describe a G3BP1-induced retrograde transport blockade that triggers stellate cell activation and liver fibrosis.

Why it matters

The work proposes a molecular pathway linking a transport blockade and splicing changes to stellate cell activation, which may help researchers understand how liver fibrosis develops.

Who’s affected

  • researchers studying liver fibrosis, hepatic stellate cells and intracellular transport

Nature Communications, Published online: 21 November 2026; doi:10.1038/s41467-026-79478-6 Liver fibrosis is driven by hepatic stellate cell activation, but its molecular drivers remain unclear. Here, the authors show that G3BP1 promotes COPI alternative splicing via SRPK1–hnRNPM…

Timeline

  1. Published online in Nature Communications

  2. nature.com

    G3BP1-induced retrograde transport blockade triggers HSC activation and liver fibrosis via COPI alternative splicing

How do you feel about this?

0 Comments

    G3BP1-induced retrograde transport blockade triggers HSC activation and liver fibrosis via COPI alternative splicing – The Morning Science